[en] Lymphocyte homeostasis is determined by a critical balance between cell proliferation and death, an equilibrium which is deregulated in bovine leukemia virus (BLV)-infected sheep. We have previously shown that an excess of proliferation occurs in lymphoid tissues and that the peripheral blood population is prone to increased cell death. To further understand the mechanisms involved, we evaluated the physiological role of the spleen in this accelerated turnover. To this end, B lymphocytes were labeled in vivo using a fluorescent marker (carboxyfluorescein diacetate succinimidyl ester), and the cell kinetic parameters (proliferation and death rates) of animals before and after splenectomy were compared. We show that the enhanced cell death observed in BLV-infected sheep is abrogated after splenectomy, revealing a key role of the spleen in B-lymphocyte dynamics.
Disciplines :
Veterinary medicine & animal health Oncology
Author, co-author :
Florins, Arnaud-Francois ; Université de Liège - ULiège > Chimie et bio-industries > Centre de Bio. Fond. - Section de Biologie cell. et moléc.
Gillet, Nicolas ; Université de Liège - ULiège > Chimie et bio-industries > Biologie cell. et moléc.
Achachi, A., A. Florins, N. Gillet, C. Debacq, P. Urbain, G. M. Foutsop, F. Vandermeers, A. Jasik, M. Reichert, P. Kerkhofs, L. Lagneaux, A. Burny, R. Kettmann, and L. Willems. 2005. Valproate activates bovine leukemia virus gene expression, triggers apoptosis, and induces leukemia/lymphoma regression in vivo. Proc. Natl. Acad. Sci. USA 102:10309-10314.
Asquith, B., C. Debacq, A. Florins, N. Gillet, T. Sanchez-Alcaraz, A. Mosley, and L. Willems. 2006. Quantifying lymphocyte kinetics in vivo using carboxyfluorescein diacetate succinimidyl ester (CFSE). Proc. Biol. Sci. 273:1165-1171.
Brigden, M. L. 2001. Detection, education and management of the asplenic or hyposplenic patient. Am. Fam. Physician 63:499-506.
Brigden, M. L., and A. L. Pattullo. 1999. Prevention and management of overwhelming postsplenectomy infection - an update. Crit. Care Med. 27: 836-842.
Burny, A., F. Bex, C. Bruck, Y. Cleuter, D. Dekegel, J. Ghysdael, R. Kettmann, M. Leclercq, M. Mammerickx, and D. Portetelle. 1979. Biochemical and epidemiological studies on bovine leukemia virus (BLV). Haematol. Blood Transfus. 23:445-452.
Burny, A., Y. Cleuter, R. Kettmann, M. Mammerickx, G. Marbaix, D. Portetelle, A. Van den Broeke, L. Willems, and R. Thomas. 1987. Bovine leukaemia: facts and hypotheses derived from the study of an infectious cancer. Cancer Surv. 6:139-159.
Chevallier, N., M. Berthelemy, D. Le Rhun, V. Laine, D. Levy, and I. Schwartz-Cornil. 1998. Bovine leukemia virus-induced lymphocytosis and increased cell survival mainly involve the CD11b+ B-lymphocyte subset in sheep. J. Virol. 72:4413-4420.
Coles, R. M., S. N. Mueller, W. R. Heath, F. R. Carbone, and A. G. Brooks. 2002. Progression of armed CTL from draining lymph node to spleen shortly after localized infection with herpes simplex virus 1. J. Immunol. 168:834-838.
Debacq, C., B. Asquith, P. Kerkhofs, D. Portetelle, A. Burny, R. Kettmann, and L. Willems. 2002. Increased cell proliferation, but not reduced cell death, induces lymphocytosis in bovine leukemia virus-infected sheep. Proc. Natl. Acad. Sci. USA 99:10048-10053.
Debacq, C., N. Gillet, B. Asquith, M. T. Sanchez-Alcaraz, A. Florins, M. Boxus, I. Schwartz-Cornil, M. Bonneau, G. Jean, P. Kerkhofs, J. Hay, A. Thewis, R. Kettmann, and L. Willems. 2006. Peripheral blood B-cell death compensates for excessive proliferation in lymphoid tissues and maintains homeostasis in bovine leukemia virus-infected sheep. J. Virol. 80:9710-9719.
Dietrich, P. Y., M. Henry-Amar, J. M. Cosset, S. Bodis, J. Bosq, and M. Hayat. 1994. Second primary cancers in patients continuously disease-free from Hodgkin's disease: a protective role for the spleen? Blood 84:1209-1215.
Florins, A., N. Gillet, B. Asquith, M. Boxus, C. Burteau, J. C. Twizere, P. Urbain, F. Vandermeers, C. Debacq, T. Sanchez-Alcaraz, I. Schwartz-Cornil, P. Kerkhofs, G. Jean, A. Théwis, J. B. Hay, F. Mortreux, E. Wattel, M. Reichert, A. Burny, R. Kettmann, and L. Willems. Cell dynamics and immune response to BLV infection: a unifying model. Front. Biosci., in press.
Fotiadis, C., G. Zografos, K. Aronis, T. G. Troupis, V. G. Gorgoulis, M. N. Sechas, and G. Skalkeas. 1999. The effect of various types of splenectomy on the development of B-16 melanoma in mice. Anticancer Res. 19:4235-4239.
Gabarre, J., N. Azar, T. Ben Othman, S. Gharakhanian, R. De Sahb, E. Dohin, P. Sansonetti, P. Langlois, J. P. Chigot, and M. Echard. 1991. Long-term effects of splenectomy for immune thrombopenic purpura related to human immunodeficiency virus. A retrospective study from 2 groups, with and without splenectomy. Presse Med. 20:2239-2245. (In French.)
Golomb, H. M., and J. W. Vardiman. 1983. Response to splenectomy in 65 patients with hairy cell leukemia: an evaluation of spleen weight and bone marrow involvement. Blood 61:349-352.
Gupta, V. K., I. McConnell, R. G. Dalziel, and J. Hopkins. 1998. Two B cell subpopulations have distinct recirculation characteristics. Eur. J. Immunol. 28:1597-1603.
Han, X. Y., P. Lin, H. M. Amin, and A. Ferrajoli. 2005. Postsplenectomy cytomegaloviral mononucleosis: marked lymphocytosis, TCRgamma gene rearrangements, and impaired IgM response. Am. J. Clin. Pathol. 123:612-617.
Hinuma, Y., K. Nagata, M. Hanaoka, M. Nakai, T. Matsumoto, K. I. Kinoshita, S. Shirakawa, and I. Miyoshi. 1981. Adult T-cell leukemia: antigen in an ATL cell line and detection of antibodies to the antigen in human sera. Proc. Natl. Acad. Sci. USA 78:6476-6480.
Hull, C. C., P. Galloway, N. Gordon, S. L. Gerson, N. Hawkins, and T. A. Stellato. 1988. Splenectomy and the induction of murine colon cancer. Arch. Surg. 123:462-464.
Joag, S. V., E. B. Stephens, R. J. Adams, L. Foresman, and O. Narayan. 1994. Pathogenesis of SIVmac infection in Chinese and Indian rhesus macaques: effects of splenectomy on virus burden. Virology 200:436-446.
Kerkhofs, P., H. Heremans, A. Burny, R. Kettmann, and L. Willems. 1998. In vitro and in vivo oncogenic potential of bovine leukemia virus G4 protein. J. Virol. 72:2554-2559.
Kotzin, B. L., and S. Strober. 1980. Role of the spleen in the growth of a murine B cell leukemia. Science 208:59-61.
Kraal, G., H. ter Hart, C. Meelhuizen, G. Venneker, and E. Claassen. 1989. Marginal zone macrophages and their role in the immune response against T-independent type 2 antigens: modulation of the cells with specific antibody. Eur. J. Immunol. 19:675-680.
Kreja, L., and H. J. Seidel. 1985. On the role of the spleen in Friend virus (F-MuLV-P) erythroleukemia. Exp. Hematol. 13:623-628.
Kurihara, K., N. Harashima, S. Hanabuchi, M. Masuda, A. Utsunomiya, R. Tanosaki, M. Tomonaga, T. Ohashi, A. Hasegawa, T. Masuda, J. Okamura, Y. Tanaka, and M. Kannagi. 2005. Potential immunogenicity of adult T cell leukemia cells in vivo. Int. J. Cancer 114:257-267.
Leissinger, C. A., and W. A. Andes. 1992. Role of splenectomy in the management of hemophilic patients with human immunodeficiency virus-associated immunopathic thrombocytopenic purpura. Am. J. Hematol. 40:207-209.
Lew, A. E., R. E. Bock, J. B. Molloy, C. M. Minchin, S. J. Robinson, and P. Steer. 2004. Sensitive and specific detection of proviral bovine leukemia virus by 5′ Taq nuclease PCR using a 3' minor groove binder fluorogenic probe. J. Virol. Methods 115:167-175.
Lewis, M., and D. Swirsky. 23 September 2005. Spleen: consequences of lack of function, p. 1-10. Encyclopedia of life sciences, John Wiley & Sons. Hoboken, N.J. [Online.] http://www.els.net.
Mammerickx, M., R. Palm, D. Portetelle, and A. Burny. 1988. Experimental transmission of enzootic bovine leukosis to sheep: latency period of the tumoral disease. Leukemia 2:103-107.
Matsushita, K., N. Arima, H. Ohtsubo, H. Fujiwara, K. Arimura, T. Kukita, A. Ozaki, S. Hidaka, T. Matsumoto, and C. Tei. 2002. Poor response to prednisolone of idiopathic thrombocytopenia with human T-lymphotropic virus type I infection. Am. J. Hematol. 71:20-23.
Mebius, R. E., and G. Kraal. 2005. Structure and function of the spleen. Nat. Rev. Immunol. 5:606-616.
Milicevic, N. M., Z. Milicevic, and J. Westermann. 2002. Lymphocyte function-associated antigen-1 and intercellular adhesion molecule-1 expression on B-cell subsets and the effects of splenectomy-experimental studies. Leuk. Lymphoma 43:2071-2074.
Murakami, K., K. Okada, Y. Ikawa, and Y. Aida. 1994. Bovine leukemia virus induces CD5- B cell lymphoma in sheep despite temporarily increasing CD5+ B cells in asymptomatic stage. Virology 202:458-465.
Naessens, J. 1997. Surface Ig on B lymphocytes from cattle and sheep. Int. Immunol. 9:349-354.
Nagatani, T., T. Matsuzaki, G. Iemoto, S. Kim, N. Baba, H. Miyamoto, and H. Nakajima. 1990. Comparative study of cutaneous T-cell lymphoma and adult T-cell leukemia/lymphoma. Clinical, histopathologic, and immunohistochemical analyses. Cancer 66:2380-2386.
Oksenhendler, E., P. Bierling, S. Chevret, J. F. Delfraissy, Y. Laurian, J. P. Clauvel, and M. Seligmann. 1993. Splenectomy is safe and effective in human immunodeficiency virus-related immune thrombocytopenia. Blood 82: 29-32.
Pabst, R., and F. Trepel. 1976. The predominant role of the spleen in lymphocyte recirculation. II. Pre- and postsplenectomy retransfusion studies in young pigs. Cell Tissue Kinet. 9:179-189.
Ristevski, B., A. J. Young, L. Dudler, R. N. Cahill, W. Kimpton, E. Washington, and J. B. Hay. 2003. Tracking dendritic cells: use of an in situ method to label all blood leukocytes. Int. Immunol. 15:159-165.
Saji, S., J. Sakamoto, S. Teramukai, K. Kunieda, Y. Sugiyama, Y. Ohashi, H. Nakazato, et al. 1999. Impact of splenectomy and immunochemotherapy on survival following gastrectomy for carcinoma: covariate interaction with immunosuppressive acidic protein, a serum marker for the host immune system. Surg. Today 29:504-510.
Sakai, R., A. Maruta, N. Tomita, J. Taguchi, S. Fujisawa, K. Ogawa, S. Motomura, F. Kodama, H. Mohri, and Y. Ishigatsubo. 1999. Improvement of quality of life after splenectomy in an HTLV-I carrier with T-cell prolymphocytic leukemia. Leuk. Lymphoma 35:607-611.
Seabrook, T. J., W. R. Hein, L. Dudler, and A. J. Young. 2000. Splenectomy selectively affects the distribution and mobility of the recirculating lymphocyte pool. Blood 96:1180-1183.
Suarez, F., O. Lortholary, O. Hermine, and M. Lecuit. 2006. Infection-associated lymphomas derived from marginal zone B cells: a model of antigen-driven lymphoproliferation. Blood 107:3034-3044.
Timens, W., A. Boes, T. Rozeboom-Uiterwijk, and S. Poppema. 1989. Immaturity of the human splenic marginal zone in infancy. Possible contribution to the deficient infant immune response. J. Immunol. 143:3200-3206.
Trainin, Z., J. Brenner, R. Meirom, and H. Ungar-Waron. 1996. Detrimental effect of bovine leukemia virus (BLV) on the immunological state of cattle. Vet. Immunol. Immunopathol. 54:293-302.
Tsoukas, C. M., N. F. Bernard, M. Abrahamowicz, H. Strawczynski, G. Growe, R. T. Card, and P. Gold. 1998. Effect of splenectomy on slowing human immunodeficiency virus disease progression. Arch. Surg. 133: 25-31.
Van der Maaten, M. J., J. M. Miller, and M. J. Schmerr. 1982. Role of the spleen in the pathogenesis of experimentally induced bovine leukemia virus infection. Vet. Microbiol. 7:411-418.
Velanovich, V., and M. Shurafa. 2000. Laparoscopic excision of accessory spleen. Am. J. Surg. 180:62-64.
Wijburg, O. L., M. H. Heemskerk, C. J. Boog, and N. Van Rooijen. 1997. Role of spleen macrophages in innate and acquired immune responses against mouse hepatitis virus strain A59. Immunology 92:252-258.
Willems, L., A. Burny, D. Collete, O. Dangoisse, F. Dequiedt, J. S. Gatot, P. Kerkhofs, L. Lefebvre, C. Merezak, T. Peremans, D. Portetelle, J. C. Twizere, and R. Kettmann. 2000. Genetic determinants of bovine leukemia virus pathogenesis. AIDS Res. Hum. Retrovir. 16:1787-1795.
Willems, L., A. Burny, O. Dangoisse, D. Colette, F. Dequiedt, J. S. Gatot, P. Kerkhofs, L. Lefebvre, C. Merezak, D. Portetelle, J. C. Twizere, and R. Kettman. 1999. Bovine leukemia virus as a model for human T-cell leukemia virus. Curr. Top. Virol. 1:139-167.
Willems, L., P. Kerkhofs, F. Dequiedt, D. Portetelle, M. Mammerickx, A. Burny, and R. Kettmann. 1994. Attenuation of bovine leukemia virus by deletion of R3 and G4 open reading frames. Proc. Natl. Acad. Sci. USA 91:11532-11536.
Willems, L., R. Kettmann, F. Dequiedt, D. Portetelle, V. Voneche, I. Cornil, P. Kerkhofs, A. Burny, and M. Mammerickx. 1993. In vivo infection of sheep by bovine leukemia virus mutants. J. Virol. 67:4078-4085.
Yamagishi, H., T. Oka, I. Hashimoto, N. R. Pellis, and B. D. Kahan. 1984. The role of the spleen in tumor bearing host: II. The influence of splenectomy in mice. Jpn. J. Surg. 14:72-77.
Yoshida, M., I. Miyoshi, and Y. Hinuma. 1982. Isolation and characterization of retrovirus from cell lines of human adult T-cell leukemia and its implication in the disease. Proc. Natl. Acad. Sci. USA 79:2031-2035.
Young, A. J., W. L. Marston, M. Dessing, L. Dudler, and W. R. Hein. 1997. Distinct recirculating and nonrecirculating B-lymphocyte pools in the peripheral blood are defined by coordinated expression of CD21 and L-selectin. Blood 90:4865-4875.
Zandvoort, A., and W. Timens. 2002. The dual function of the splenic marginal zone: essential for initiation of anti-TI-2 responses but also vital in the general first-line defense against blood-borne antigens. Clin. Exp. Immunol. 130:4-11.